Navigation Links
Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
Date:9/24/2010

dialysis, who are being treated with zidovudine for HIV infection, and to reduce the need for transfusion in anemic patients who are scheduled for elective noncardiac, nonvascular surgery.  Depending on the country in which Epoetin alfa is marketed, these indications may differ.

PROCRIT is licensed from Amgen and manufactured by Amgen in Puerto Rico.

IMPORTANT SAFETY INFORMATIONWARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR EVENTS, THROMBOEMBOLIC EVENTS, STROKE and INCREASED RISK OF TUMOR PROGRESSION OR RECURRENCE Chronic Renal Failure:

  • In clinical studies, patients experienced greater risks for death, serious cardiovascular events, and stroke when administered erythropoiesis-stimulating agents (ESAs) to target hemoglobin levels of 13 g/dL and above.
  • Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL.

  • Cancer:

  • ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in some clinical studies in patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers (see WARNINGS: Table 1).
  • To decrease these risks, as well as the risk of serious cardio- and thrombovascular events, use the lowest dose needed to avoid red blood cell transfusion.
  • Because of these risks, prescribers and hospitals must enroll in and comply with the ESA APPRISE Oncology Program to prescribe and/or dispense PROCRIT to patients with cancer. To enroll in the ESA APPRISE Oncology Program, visit www.esa-apprise.com or call 1-866-284-8089 for further assistance.
  • Use ESAs only for treatment of anemia due to concomitant myelosuppressive chemotherapy.
  • ESAs are not indicated for patients receiving myelosuppressive therapy when the anticipated outcome is cure.
  • Dis
    '/>"/>

  • SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related medicine technology :

    1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
    2. Medarex to Receive Milestone Payment from Amgen
    3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
    4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
    5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
    6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
    7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
    8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
    9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
    10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
    11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... Dec. 23, 2014  Advanced Medical Isotope Corporation ... primarily in the development of brachytherapy devices and ... announced that it has filed a de ... Administration ("FDA") for marketing clearance for its patented ... the U.S. Food, Drug and Cosmetic Act (the ...
    (Date:12/24/2014)... 2014  Lockton Dunning Benefits, the ... the addition of Vice President Kim Foerster ... Pharmacy Consulting team, Excelsior Solutions. ... to the position.  Most recently, she worked as ... Specialty Pharmacy, where she has held various managerial ...
    (Date:12/24/2014)... , Dec. 23, 2014  Medical Science Liaisons ... the key link between the medical device industry and ... more in the coming years as the device industry ... According to research by benchmarking firm, Best Practices, ... gain an important edge is by harnessing new technology ...
    Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Kim Foerster Joins Lockton Companies 2Role of Medical Science Liaisons Evolving in Medical Device Sector 2
    ... eTransX recently unveiled the latest version of eTX ... application integration engine. Version 6 delivers on the ... healthcare information systems. The latest version of the ... and enhancements that generate greater efficiencies in creating ...
    ... Calif., Dec. 17, 2010 SurgiCount Medical, the wholly-owned ... Board: PSTX ) today announced the successful ... Michigan Health System located in Ann Arbor, Michigan.  The ... of the most common surgical errors, retained surgical sponges. ...
    Cached Medicine Technology:eTransX Unveils Latest Version of Its eTX HEMI 2SurgiCount Medical Announces the Successful Implementation of the Safety-Sponge® System at the University of Michigan Health System 2SurgiCount Medical Announces the Successful Implementation of the Safety-Sponge® System at the University of Michigan Health System 3
    (Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping tips ... the models at LunaDress.co.uk come with big discounts, up to 80 ... can turn out to be a most exciting memory and can ... bring surprise to a wedding. On the updated fashion blog, ladies ... for a big day . , Going out with friends to ...
    (Date:12/25/2014)... risk of burns from fires and cooking accidents increases ... cautious, an expert says. "Between Thanksgiving and New ... coming in with burns," said Dr. Steven Sandoval, medical ... of Stony Brook University Hospital in New York. ... not careful, could quickly turn tragic," Sandoval said in ...
    (Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
    (Date:12/25/2014)... 2014 AngelWeddingDress.com tries its best to ... realm. Today, the business has introduced its new collection ... dress promotion. , The new prom outfits are guaranteed ... dress lover. They are specially designed for 2015. Anyone ... dresses should visit its website before Jan. 26, 2015, ...
    (Date:12/25/2014)... December 25, 2014 “ SmileStix ” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review and shared ... create personal stickers. , The old saying goes, “A picture ... of words that can describe a single image, because each ...
    Breaking Medicine News(10 mins):Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
    ... to be remotely monitored through XTend,s Disease ... ... (Pink Sheets: XMDC) announced today the company has begun a,remote diabetic ... the initial program., The program, facilitated through local physicians in ...
    ... has shown that the main metabolite of the insecticide ... but there has been no explanation for this observation ... access journal Breast Cancer Research shows how DDT could ... Aube and colleagues from Universite Laval and Institut national ...
    ... LANDOVER, Md., Feb. 13 Valentine,s Day is,not just ... saint of,lovers, St. Valentine, takes on greater meaning when ... -- a common neurological condition that,causes seizures, and affects ... States, according to the Epilepsy Foundation., Some accounts ...
    ... Feb. 13 ReBuilder Medical,Technologies, Inc. (Pink ... art,electronic devices for diabetic peripheral neuropathy, Molluscum,Contagiosum, ... over last year, details,are available on their ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ), "The ...
    ... SEGUNDO, Calif., Feb. 13 DaVita Inc.,(NYSE: DVA ... ended December,31, 2007. Net income for the three months ... share, as compared to $74.1 million, or $0.70 per,share, ... http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ), Net income for the year ended ...
    ... Cardiac Science,Corporation (Nasdaq: CSCX ), a ... informatics products, announced today,that it will present at ... Conference on Wednesday, February 20, 2008 at the ... vice president and chief,financial officer, will present the ...
    Cached Medicine News:Health News:XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program 2Health News:How DDT metabolite disrupts breast cancer cells 2Health News:ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006 2Health News:DaVita 4th Quarter 2007 Results 2Health News:DaVita 4th Quarter 2007 Results 3Health News:DaVita 4th Quarter 2007 Results 4Health News:DaVita 4th Quarter 2007 Results 5Health News:DaVita 4th Quarter 2007 Results 6Health News:DaVita 4th Quarter 2007 Results 7Health News:DaVita 4th Quarter 2007 Results 8Health News:DaVita 4th Quarter 2007 Results 9Health News:DaVita 4th Quarter 2007 Results 10Health News:DaVita 4th Quarter 2007 Results 11Health News:DaVita 4th Quarter 2007 Results 12Health News:DaVita 4th Quarter 2007 Results 13Health News:DaVita 4th Quarter 2007 Results 14Health News:DaVita 4th Quarter 2007 Results 15Health News:DaVita 4th Quarter 2007 Results 16Health News:DaVita 4th Quarter 2007 Results 17Health News:Cardiac Science to Present at the Roth Capital Partners 20th Annual Growth Stock Conference 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: